Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
How would you manage out-of-field nodal recurrence of NSCLC post definitive CRT and adjuvant immunotherapy?
Answer from: Radiation Oncologist at Community Practice
Systemic therapy if distant disease. Radical chemoRT followed by immune therapy if solitary recurrence.
Comments
Radiation Oncologist at Yale School of Medicine
I agree. Before irradiating additional nodal disea...
Radiation Oncologist at Torrance Memorial Medical Center
Dr. @Park, would you ever just do SBRT rather than...
Radiation Oncologist at Yale School of Medicine
Rarely, but I've done low-dose SBRT (around 30-35 ...
10822
10834
10839
Sign in or Register to read more
20296
Related Questions
Under what circumstances, if any, would you wait on initiating a TKI for metastatic recurrence of a Stage III NSCLC which occurred while on consolidative durvalumab to minimize pneumonitis risk?
Do you perform EBUS-TBNA for staging in patients with biopsy proven malignant lung nodules with no lymphadenopathy on CT chest and PET scan?
Is there a role for the addition of radiation to preoperative chemoimmunotherapy in NSCLC with limited N2 disease planned for surgery?
Do you offer adjuvant durvalumab for stage I small cell lung cancer following SBRT or surgery?
What radiation treatment volume would you include in chemoradiation given for perihilar lymph node recurrence after surgical resection and mediastinal lymph node dissection for NSCLC?
For NSCLC patients treated with neoadjuvant chemoimmunotherapy and surgery with ypN2 disease, what factors would cause you to recommend PORT?
Would you offer adjuvant radiation therapy for a completely resected, node positive mucoepidermoid carcinoma of the lung?
How do you assess whether a patient will be a good DIBH candidate for lung or abdomen treatments?
Is there a role for radiation to the primary mediastinal disease in metastatic thymic neuroendocrine carcinoma with the primary as the only residual disease after systemic therapy?
Would you offer SBRT as an alternative to surgery for an atypical carcinoid lung tumor?
I agree. Before irradiating additional nodal disea...
Dr. @Park, would you ever just do SBRT rather than...
Rarely, but I've done low-dose SBRT (around 30-35 ...